The COVID-19 pandemic has not influenced survival outcomes of head and neck cancer squamous cell carcinomas in the West of Scotland: a retrospective cohort study
- PMID: 41781658
- PMCID: PMC12960927
- DOI: 10.1038/s44276-026-00203-3
The COVID-19 pandemic has not influenced survival outcomes of head and neck cancer squamous cell carcinomas in the West of Scotland: a retrospective cohort study
Abstract
Background: The COVID-19 pandemic posed significant disruptions to healthcare worldwide. This study aimed to assess if the COVID-19 pandemic affected short-term survival outcomes of patients with head and neck cancer squamous cell carcinoma (HNSCC) in the west of Scotland.
Methods: A retrospective cohort analysis was conducted using regional centre data. Patients diagnosed with HNSCC during pre-pandemic (June-October 2019), intra-pandemic (June-October 2020) and post(peak)-pandemic (June-October 2022) were compared. Demographic, behavioural, clinical, and survival data were analysed using Kaplan-Meier curves, Cox-regression, and logistic-regression for stage at diagnosis.
Results: A total of 707 patients were included. While the 2020 cohort exhibited an increase in advanced-stage disease (67.5% p = 0.01), no statistically significant difference in overall survival was observed across the study period (p = 0.22). Cox-regression showed no associations between year of diagnosis and mortality, even after multivariable adjustment for confounders. Survival was strongly associated with age, performance status, stage, and HPV status among oropharynx cancers. Socioeconomic inequalities persisted, with the poorest survival among those from the most socioeconomically deprived areas (p = 0.02).
Conclusions: While an increase in advanced-stage HNSCC diagnoses was observed in the West of Scotland during 2020, short-term survival outcomes remained comparable to pre- and post-pandemic.
© 2026. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethical approval and consent to participate: Local clinical NHS Caldicott Guardian and University of Glasgow ethical approvals (Project number 200240340) were obtained for this cohort analysis of minimally identifiable, routinely consented, clinical data.
Figures
References
Grants and funding
LinkOut - more resources
Full Text Sources